Clinical and Cost Outcomes of an Integrative Medicine IPA

https://doi.org/10.1016/j.jmpt.2004.04.007Get rights and content

Abstract

Objective

We hypothesized that primary care physicians (PCPs) specializing in a nonpharmaceutical/nonsurgical approach as their primary modality and utilizing a variety of complementary/alternative medicine (CAM) techniques integrated with allopathic medicine would have superior clinical and cost outcomes compared with PCPs utilizing conventional medicine alone.

Design

Incurred claims and stratified randomized patient surveys were analyzed for clinical outcomes, cost offsets, and member satisfaction compared with normative values. Comparative blinded data, using nonrandomized matched comparison groups, was analyzed for age/sex demographics and disease profiles to examine sample bias.

Setting

An integrative medicine independent provider association (IPA) contracted with a National Committee for Quality Assurance (NCQA)-accredited health maintenance organization (HMO) in metropolitan Chicago.

Subjects

All members enrolled with the integrative medicine IPA from January 1, 1999 through December 31, 2002.

Results

Analysis of clinical and cost outcomes on 21,743 member months over a 4-year period demonstrated decreases of 43.0% in hospital admissions per 1000, 58.4% hospital days per 1000, 43.2% outpatient surgeries and procedures per 1000, and 51.8% pharmaceutical cost reductions when compared with normative conventional medicine IPA performance for the same HMO product in the same geography over the same time frame.

Conclusion

In the limited population studied, PCPs utilizing an integrative medical approach emphasizing a variety of CAM therapies had substantially improved clinical outcomes and cost offsets compared with PCPs utilizing conventional medicine alone. While certainly promising, these initial results may not be consistent on a larger and more diverse population.

Introduction

The escalation of medical expenditures is an urgent problem. Although various types of managed care, once thought by some to be part of the solution to increasing medical expenditures, have been used for decades, little evidence exists that this or any other cost-containment strategy has significantly influenced a 50-year trend of increasing medical expenses on a long-term basis.1., 2., 3., 4., 5. Managed care rates are now posting double-digit annual increases,6 with pharmaceuticals estimated to account for 50% of the cost increases over the past 3 years.7

While the health care system excels in acute care and crisis disease state management, this accounts for only a small percentage of the total medical care in both cost and volume rendered daily.8 The greater health care burden is the prevention and treatment of the multiple chronic disorders in the general population that now account for the majority of health care expenditures.9

Chronic diseases are a major public problem in the United States. Currently, about 40% of the US population (approximately 100 million Americans) suffer from at least 1 chronic disorder.9 This high level of prevalence within the United States raises concerns about the efficacy and limitations of our conventional health care system.10 Such concerns appear to contribute to public and professional interest in alternatives to conventional modern medicine.

Studies now suggest that 50% of the deaths11 and 70% of the diseases12 in the United States are caused by unhealthy lifestyle habits such as smoking, alcohol abuse, and improper diet. Unlike the preantibiotic era when mortality was primarily because of infectious diseases, our nation now faces a behavior-induced epidemic of chronic illness. Managed care and government policy makers are faced with the dilemma of trying to decrease medical costs caused mainly by lifestyle choices while continuing to maintain personal freedom of choice.

Iatrogenic illness (an adverse condition arising from the treatment of a physician) is estimated as the etiology of 15% of our hospital days, and pharmaceuticals are estimated to cause between 100,000 to 250,000 deaths per year,13., 14. as well as nonquantifiable morbidity. Prescription drug addiction, administering the wrong drug, and prescription overdoses are a large percentage15., 16. of reported deaths by medical mistake. The National Conference of State Legislatures, November/December 2000, estimates the cost of lost income, disability, and health care resulting from medical mistakes is as much as $29 billion per year.17

Given these facts, it may be time to rethink this country's current medical model with its overall reliance on pharmaceuticals as a first line option. Complementary/alternative medicine is one viable approach that should be considered because it addresses the privacy, quality, and expense considerations facing health care delivery systems.

Unlike conventional medical education and care, which relies heavily on high technology and pharmaceuticals, complementary/alternative medicine exists in a “low-tech arena.” “Low-tech” therapeutic modalities such as chiropractic manipulation, homeopathy, stress management, massage, and use of herbal medicines are perceived by the public as more gentle, less morbid, and less costly than conventional modern medicine.18

Many previous studies on various complementary/alternative medicine (CAM) modalities have illustrated improved clinical outcomes and substantially decreased costs compared with standard conventional medical practice protocols.19., 20., 21., 22., 23., 24., 25., 26., 27., 28., 29., 30., 31., 32., 33., 34., 35., 36., 37., 38., 39., 40., 41., 42., 43., 44. However, while individual diagnostic categories have been analyzed, a study of the clinical outcomes and cost effectiveness of primary care physicians (PCPs) specializing in CAM, and more particularly chiropractic care, within the context of a classical gatekeeper health maintenance organization (HMO) has never previously been attempted.

Section snippets

Methods

Data reported in this study were drawn from incurred claims data, originating from both the integrative medicine independent provider association (IPA) and the HMO. The IPA data included all inpatient and outpatient encounters for both cost and diagnosis, including the professional fees associated with patient referrals, outpatient diagnostics (encounters and costs), and outpatient laboratories (encounters and costs). The HMO data included the encounters and costs of all pharmaceutical usage,

Outcomes: Clinical

These data points are based on the HMO's corroborated data for the 4 calendar years 1999, 2000, 2001, and 2002. AMI's encounter data represent 21,743 member months over this 4-year period. The traditional managed care benchmarks depicted in Table 4 illustrate AMI's apparent superior clinical outcomes compared with conventional IPA performance over the same time frame.

AMI's outcomes are reported as “percentage utilization” and “percentage reduction” versus the HMO network as a whole. Percentage

Discussion

Certainly, we now appreciate the importance of lifestyle and environmental factors in the optimization of health and subsequent prevention of disease. Reliance on the conventional medical model, in which pharmaceuticals and surgical interventions represent first-line treatment, may not provide the best therapeutic index to our patients. The AMI model seems to demonstrate the potential superiority of an integrated health system in which chiropractic and CAM therapies play a significant primary

Conclusion

AMI's integrative medicine IPA represents a new model in the delivery of managed care. This unique model has demonstrated promising clinical and cost outcomes by the integration of complementary alternative medicine with conventional medicine in a defined program encompassing physician selection, medical management, and scientific accountability. AMI believes this model to be replicable on a much larger scale and is currently implementing different programs, such as preferred provider

Acknowledgements

We wish to acknowledge the following people: Dr Dana Lawrence for editing assistance, Jay M. Jaffe, for actuarial consulting, Marcia Marek, Angela Miller, Rose H. Homma, and Nancy J. Rothermel for secretarial support, and all of our AMI HMO Primary Care Chiropractic physicians for their spirit and dedication to this project.

References (56)

  • LGF Giles et al.

    Chronic spinal pain syndromes: a clinical pilot trial comparing acupuncture, a non-steroidal anti-inflammatory drug, and spinal manipulation

    J Manipulative Physiol Ther

    (1999)
  • S Jencks et al.

    Containing U.S. health care costs: what bullet to bite?

    Health Care Financ Rev Annu Suppl

    (1991)
  • Managed competition and its potential role to reduce health spending

    (1993)
  • E Teisberg et al.

    Making competition in health care work

    Harv Bus Rev

    (1994)
  • K Davis et al.

    Health care cost containment

    (1990)
  • S Burner et al.

    National health expenditures projections through 2030

    Health Care Financ Rev

    (1992)
  • RT Luke

    Health care in the United States: current and future challenges

    Manag Care

    (2001)
  • CA Cowan et al.

    National health expenditures: 1999

    Health Care Financ Rev

    (2001)
  • J Hadley et al.

    Financial pressure and competition. Changes in hospital efficiency and cost-shifting behavior

    Med Care

    (1996)
  • C Hoffman et al.

    Persons with chronic conditions: their prevalence and costs

    JAMA

    (1996)
  • JE South-Paul et al.

    How does a changing country change family practice?

    Fam Med

    (2001)
  • J McGinnis et al.

    Actual cause of death in the United States

    JAMA

    (1993)
  • Healthy people 2000: national health promotion and disease prevention objectives

    (1991)
  • US Department of Health, Education and Welfare. Task force on preparation of drugs: final report. Mod Med p. 35. Cited...
  • DC Classen et al.

    Computerized surveillance of adverse drug events in hospital patients

    JAMA

    (1991)
  • RA Hayward

    Counting deaths due to medical errors

    JAMA

    (2002)
  • RA Gabel

    Counting deaths due to medical errors

    JAMA

    (2002)
  • New drug abuse trend: prescription medication. Associated Press. April 11, 2001. Cited by: Welshimer B. Health care in...
  • JE Sanchez

    A look in the mirror. A critical and exploratory study of public perceptions of the chiropractic profession in New Jersey

    J Manipulative Physiol Ther

    (1991)
  • TW Meade et al.

    Low back pain of mechanical origin: randomized comparison of chiropractic and hospital outpatient treatment

    BMJ

    (1990)
  • TW Meade et al.

    Randomized comparison of chiropractic and hospital outpatient management for low back pain: results from extended follow-up

    BMJ

    (1995)
  • BW Koes et al.

    The effectiveness of manual therapy, physiotherapy, and treatment by the general practitioner for nonspecific neck and back complaints: a randomized clinical trial

    Spine

    (1992)
  • J Triano et al.

    Manipulative therapy versus education programs in chronic low back pain

    Spine

    (1995)
  • G Bronfort et al.

    Trunk exercise combined with spinal manipulative or NSAID therapy for chronic low back pain: a randomized, observer-blinded clinical trial

    J Manipulative Physiol Ther

    (1996)
  • WH Kirklady-Willis et al.

    Spinal manipulation in the treatment of low-back pain

    Can Fam Physician

    (1985)
  • MH Pope et al.

    A prospective randomized three-week trial of spinal manipulation, transcutaneous muscle stimulation, massage and corset in the treatment of subacute low back pain

    Spine

    (1994)
  • S Blomberg et al.

    A controlled multicenter trial of manual therapy in low back pain: initial status, sick leave and pain score during follow-up

    J Orthop Med

    (1994)
  • M Berquist-Ullman et al.

    Acute low back pain in industry: a controlled prospective study with special reference to therapy and confounding factors

    Acta Orthop Scand

    (1977)
  • Cited by (38)

    • Cost-Efficiency and Effectiveness of Including Doctors of Chiropractic to Offer Treatment Under Medicaid: A Critical Appraisal of Missouri Inclusion of Chiropractic Under Missouri Medicaid

      2019, Journal of Chiropractic Humanities
      Citation Excerpt :

      Does the consumption of DC and CAM services reduce the need for more expensive medical care, or does it merely supplement and add on to medical cost rather than replacing it?33 They studied claims data from large insurers and cost-effectiveness studies and concluded that CAM coverage does not increase health care costs for the general population.34-38 Before the Martin study, a national sample had not been examined for the impact of CAM use on total health care costs or for specific types of services (eg, inpatient, outpatient, prescriptions, and emergency services).

    • The Healing Encounter

      2018, Integrative Medicine: Fourth Edition
    • Chiropractic Identity: A Neurological, Professional, and Political Assessment

      2016, Journal of Chiropractic Humanities
      Citation Excerpt :

      These findings would seem to position doctors of chiropractic in the United States on a spectrum somewhere between primary care providers and specialists upon referral. At the very least, first contact for a minimum of musculoskeletal conditions would be indicated for doctors of chiropractic, buttressed by such findings by Sarnat et al102,103 that demonstrated major reductions of hospital days, outpatient surgical procedures, and health care costs when doctors of chiropractic were given first-contact privileges to patients within an independent physicians’ association. Beyond managing only musculoskeletal conditions, doctors of chiropractic in 4 medical underserved communities (rural and urban underserved) tended to deliver primary care services.104

    • Philosophy of Integrative Medicine

      2012, Integrative Medicine, Third Edition
    • Creating a Greener Clinic

      2012, Integrative Medicine, Third Edition
    View all citing articles on Scopus
    View full text